Figure 2From: Low levels of ATM in breast cancer patients with clinical radiosensitivityScatterplot showing the level of the ATM protein for LCLs established for the following population groups. Breast cancer patients with no adverse reaction to radiotherapy referred to as non-reactor controls (NRC); Women with SLE; Cancer patients with severe acute normal tissue reactions to radiotherapy (RS-acute); Patients with severe acute and late reactions (RS-A/L); Patients with only severe late reactions (RS-Late); Obligate A-T heterozygotes (ATH - Note: the 4 highest expressing ATH carry null mutations); A-T patients (A-T). ATM protein densities were plotted as a percentage of the level of the ‘highest ATM expresser’.Back to article page